ABSTRACT
INTRODUCTION
Absent pulmonary valve syndrome (APVS) is a rare congenital heart defect characterized by absent or rudimentary pulmonary valve leaflets 1, 2 . In the majority of cases, the ductus arteriosus (DA) is absent, the pulmonary annulus is restrictive and stenotic with to-and-fro blood flow over the dysplastic pulmonary valve, and there is severe dilatation of the pulmonary trunk and its branches ( Figure 1 ). Marked pulmonary branch dilatation and concomitant cardiomegaly may result in bronchomalacia secondary to bronchial compression, leading to respiratory compromise at birth and chronic obstructive lung disease later in life. In addition to the cardiac defect itself, APVS is therefore associated with significant perinatal mortality and morbidity [3] [4] [5] [6] [7] . Prenatal APVS accounts for 15-20% of all fetuses with tetralogy of Fallot (TOF) and 1% of all congenital cardiac defects, whereas its postnatal incidence is lower, comprising 3-6% of all TOF and 0.2-0.4% of all congenital cardiac defects 1, 8, 9 . This difference in prenatal and postnatal series may be explained by the high rate of spontaneous or iatrogenic loss during pregnancy attributable to intrauterine cardiac failure and the association with chromosomal anomalies 6, 10, 11 . It is therefore unsurprising that prenatal series have reported poor survival rates, whereas outcomes in postnatal studies tend to be better 5, 12, 13 . However, knowledge of the outcome of prenatally diagnosed APVS is limited; only five large prenatal series (including 12-21 cases) have been published in the last decade, with survival rates ranging from 20% in the older studies 3, 6, 10 to > 50% in the more recent studies 11, 14 . Furthermore, previous studies on APVS almost exclusively included cases from the second trimester onwards, whereas only a few cases in the first trimester have been reported 15 . As dilation of the pulmonary arteries does not occur prior to 20 weeks' gestation 6, 16 , the diagnosis of APVS in the first trimester relies mainly on the detection of to-and-fro blood flow over the pulmonary valve and ductal arch (Figure 2 ), in addition to enlarged nuchal translucency (NT) thickness and abnormal Doppler flow velocity waveforms in all systemic arteries and the ductus venosus (DV) 6, 15 . The diagnosis of APVS with agenesis of the DA is less straightforward as it is solely based on the detection of regurgitation over the pulmonary valve, which might easily be overlooked.
The aim of this study was to assess the spectrum of associated cardiac, extracardiac and chromosomal anomalies, intrauterine course and outcome in a relatively large contemporary series of prenatally diagnosed APVS from the first trimester onward.
SUBJECTS AND METHODS
All cases with a prenatal diagnosis of APVS between 2002 and 2014 in the perinatal databases of two tertiary referral centers for prenatal medicine and fetal echocardiography (Universities of Bonn and Cologne, Germany) were reviewed retrospectively for intrauterine course and outcome. APVS was diagnosed in the presence of rudimentary or dysplastic pulmonary valve leaflets with to-and-fro blood flow in the pulmonary trunk on color and pulsed-wave Doppler ultrasound evaluation.
In both centers, anatomic examination and fetal echocardiography were performed in a standardized manner. Fetal echocardiography was performed with a segmental approach, using standardized anatomical planes incorporating pulsed-wave and color Doppler imaging 17, 18 . All ultrasound examinations were performed using 5-, 7.5-or 9-MHz sector or curved-array probes (ATL HDI 5000 and IU22, Philips, Hamburg, Germany; Voluson 730 Expert and E8, GE Medical Systems, Zipf, Austria). In the first trimester, transvaginal sonography was integral to all examinations. At both centers, a pediatric cardiologist attended at least one of the prenatal ultrasound examinations and subsequently counseled the patients. Following delivery and initial care by the attending neonatologist, all newborns were examined by a pediatric cardiologist within 12 h after birth.
Data were retrieved from medical files, stored ultrasound images and, if available, ultrasound video recordings. The following variables were assessed: maternal age; gestational age at diagnosis; gestational age at delivery; associated cardiac, extracardiac and chromosomal abnormalities; thickened NT or hydrops; patency and flow pattern of the DA; and presence of a right aortic arch (RAA). In all cases, spectral Doppler was applied to the umbilical artery (UA), fetal middle cerebral artery (MCA) and DV. Karyotyping was performed in all but three cases. In all cases at > 20 weeks' gestation, the diameter of the pulmonary valve annulus, diameter of the right pulmonary artery and cardiothoracic circumference ratio were assessed either prospectively during the scan or retrospectively on the stored images and the diameters compared with previously published normative data 19, 20 . Cases were classified according to pregnancy outcome into the following five groups: termination of pregnancy (TOP), intrauterine fetal death (IUFD), neonatal death (NND), death in infancy or childhood and survivors. NND was defined as death within the first 28 days after birth. Postnatal surgical/medical files were available for confirmation of the prenatal diagnosis in all cases of NND, childhood death and surviving children.
Five cases in this series have been included in previously published case reports 21, 22 and a case series on reversed end-diastolic flow in the UA in the first trimester 15 . Intergroup comparisons were made using the chi-square test, Student's t-test or Fisher's exact test. Values are given as mean ± SD unless otherwise indicated. P < 0.05 was considered statistically significant. The institutional review boards of the centers included in the study do not require formal approval for retrospective archived studies, therefore, ethical approval was not sought.
RESULTS
During the study period, 40 cases of APVS were diagnosed prenatally. Thirty-seven (92.5%) cases were associated with TOF and three (7.5%) had an intact ventricular septum. Agenesis of the DA was found in 20 (50.0%) cases. Laterality of the aortic arch could be ascertained in 28 cases in the second trimester and was right-sided (RAA) in 12 (30.0%). Hydrops and/or an enlarged NT was present in 13 (32.5%) cases. Mean gestational age at diagnosis of APVS was 19.7 (range, 12-34) weeks, with 10 (25.0%) cases diagnosed in the first trimester.
APVS was associated only with TOF in 15 (37.5%) cases. Chromosomal anomalies, cardiac defects (other than TOF, RAA and/or agenesis of the DA) and extracardiac anomalies were present in 18 (45.0%), four (10%) and three (7.5%) cases, respectively (Table 1) .
Among the three (7.5%) cases with APVS and an intact ventricular septum, two had additional membranous tricuspid atresia (TA) and non-compacted left ventricular myocardium, and one had an absent aortic valve. All of these cases had a patent DA and none had other cardiac, extracardiac or chromosomal anomalies.
Regarding pregnancy outcome, there were 19 (47.5%) TOPs, six (15.0%) IUFDs, four (10.0%) NNDs and 11 (27.5%) survivors with a mean follow-up of 51 (range, 12-132) months (Figures 3 and 4) . Among the 19 TOPs, 13 (68.4%) had chromosomal anomalies, two (10.5%) had additional cardiac defects (Ebstein's anomaly, absent aortic valve), one (5.3%) had bilateral renal agenesis and three (15.8%) were cases with isolated TOF and hydrops and/or enlarged NT. All six cases of IUFD had a patent DA and reversed flow during atrial contraction in the DV, MCA and UA. Hydrops and/or enlarged NT was present in five IUFD cases, two of which had lethal chromosomal anomalies. NND occurred in four cases, two of which received compassionate care due to additional extracardiac anomalies (one case each of CHARGE association (coloboma, heart disease, atresia choanae, restricted growth and/or development, genital hypoplasia and ear anomalies or deafness) and complex malformation syndrome). The remaining two infants died due to cardiac insufficiency within hours after delivery. Among the 11 survivors, three had 22q11.2 microdeletion, two had additional membranous TA and non-compacted left ventricular myocardium, and the remaining six had isolated TOF. Complete biventricular repair with patch closure of the ventricular septal defect, right ventricle to pulmonary artery conduit or homograft and bilateral pulmonary artery plication was performed in eight survivors. The remaining three infants underwent single ventricle repair with partial or total cavopulmonary connection, including both cases with TA. Only one of the 11 survivors had significant tracheal damage and had a tracheostoma until the age of 4 years. At follow-up at 13 years of age he was doing well.
In the 37 cases of APVS with TOF, patency of the DA, increased NT/hydrops, abnormal Doppler flow profiles in the DV, UA and MCA, and an earlier prenatal diagnosis were significantly associated with non-survival ( Table 2) . Of the 17 cases of TOF with a patent DA, nine (52.9%) were terminated and six (35.3%) died in utero before 21 weeks' gestation. Only two (11.8%) survived until term; one had CHARGE association and died in the neonatal period following compassionate care and the other had successful biventricular repair. In both of these cases the DA was narrow (Z-scores of -0.85 and -2.7 at 28 and 32 weeks' gestation, respectively, according to previously published normative data 23 , Figure 1 ). Only one case with reversed flow in the DV survived. In this case, the UA and MCA had normal Doppler flow patterns. None of the 15 cases with abnormal Doppler flow in the UA and/or MCA survived the intrauterine period, including all 13 cases with hydrops and all 10 cases that were diagnosed in the first trimester.
After exclusion of cases with non-cardiac adverse factors (TOP, lethal trisomy, TA, preterm delivery < 28 weeks' gestation and abstention from active postnatal care), the following parameters were significantly associated with non-survival: patency of the DA, reversed flow during atrial contraction in the DV, UA and MCA, and increased NT/hydrops (Table 2) .
In cases of APVS with TOF, abnormal Doppler flow profiles were significantly associated with patency of the DA. In the 17 cases with patent DA, 15 had reversed flow in the DV, UA and MCA, whereas no case had reversed flow among those with agenesis of the DA (P < 0.05).
All 10 cases diagnosed in the first trimester had a patent DA with to-and-fro blood flow over the pulmonary valve and reversed flow in the DV, UA and MCA, and eight had hydrops and/or enlarged NT. Conversely, the first-trimester scan was abnormal in three cases (one case each of nuchal edema, reversed flow in the DV and RAA), but the definitive diagnosis was made only at the repeat scan at 18 weeks' gestation, when the dilation of the pulmonary arteries became detectable. All of these three cases had agenesis of the DA.
All other assessed parameters, including pulmonary valve annulus Z-score, right pulmonary artery diameter Z-score and cardiothoracic ratio were not significantly associated with survival after excluding cases of TOP, lethal conditions, preterm delivery < 28 weeks' gestation and abstention from active postnatal care.
DISCUSSION
The current body of literature recognizes three variants of APVS: the predominant type of APVS with TOF and agenesis of the DA; and two very rare variants including APVS with an intact ventricular septum and a patent DA, and APVS with an intact ventricular septum and membranous TA. Whereas the former variant of APVS is highly associated with chromosomal anomalies, namely 22q11.2 microdeletion, the latter two have no reported association with chromosomal anomalies. It was therefore speculated that these variants of APVS may represent completely different pathological entities 3, 6, 10, 11, 21, 24 . In our series, we found a similar distribution of APVS variants, with 92.5% of cases associated with TOF and only 7.5% with an intact ventricular septum. APVS with TOF was frequently associated with chromosomal anomalies (45.0%), whereas all three cases of APVS with an intact ventricular septum had a normal karyotype.
In contrast to previous prenatal studies on APVS, our current cohort includes a large proportion of early diagnoses that offers novel insights into the pathophysiology of the condition, its associated diseases and important diagnostic signs. Cases diagnosed in the first and early second trimesters in our series have shed some light on the mechanism of ductal agenesis associated with TOF. Although described previously more than 40 years ago 2 , there has been an ongoing debate as to the origin of this strong association. Whereas some authors have proposed that underdevelopment of the pulmonary valve leaflets causes ductal agenesis, or vice versa, others have postulated that 80-90% of fetuses with APVS and TOF have a DA, as is the case for TOF in general, but that this subset of fetuses is likely to miscarry early in gestation due to massive aortopulmonary shunting and biventricular overload 11, [24] [25] [26] . The latter theory was supported by the few reported cases of APVS with TOF and a patent DA detected in the first trimester 15 . Our current series adds further evidence to this theory; 17 cases of APVS with TOF and patent DA were detected in our cohort, 15 of which died or were terminated because of hydrops or lethal conditions prior to 21 weeks' gestation. In both of the cases that survived to term, the DA was narrow, suggesting that only a highly restrictive DA is compatible with survival in APVS with TOF. Unfortunately, these two cases had no first-trimester scan and therefore the sonographic features in early pregnancy (flow over the ductal arch, size of the pulmonary arteries, Doppler parameters) are unknown. Even after exclusion of TOPs and other non-cardiac adverse factors, patency of the DA in fetuses with APVS and TOF was significantly associated with non-survival and the presence of abnormal Doppler parameters in the DV, UA and MCA.
It is of note that none of the 10 cases with TOF and patent DA diagnosed in the first trimester had dilatation of the pulmonary trunk and its branches; neither did the three cases with TOF and agenesis of the DA that were scanned in the first trimester but in which the definitive diagnosis was made only in the second trimester, when dilatation of the pulmonary arteries became obvious. This is in accordance with previous studies in which pulmonary dilatation could not be demonstrated prior to 20 weeks' gestation 6, 16 . Therefore, in the absence of a large ventricular septal defect or RAA, which are both important signs for the early detection of TOF, mainly cases with patent DA resulting in the typical to-and-fro flow over the ductal arch and reversed flow in the DV, UA and MCA are likely to be detected in the first trimester. This selection bias in favor of unfavorable cases certainly applies to our cohort.
Furthermore, the presence of a patent and nonrestrictive DA seems to prevent massive dilatation of the branch pulmonary arteries, as shown in our study, as well as in previous work 14 . This strengthens the assumption that the dilatation of the pulmonary arteries in APVS is a result of elevated pressure and volume load, and not of connective tissue abnormality, as is found in aneurysmal dilatation of the aorta.
The high proportion of early diagnoses in our series also modifies the spectrum of associated diseases in APVS with TOF. In contrast to previous publications in which a strong association of APVS with TOF and 22q11.2 microdeletion has been reported 3, 6, 10, 11, 14 , our study found a high incidence of trisomies 18 and 13 in addition to 22q11.2 microdeletion. This is attributable to the high proportion of first-trimester diagnoses in our cohort; of 10 cases with APVS and TOF diagnosed in the first trimester, six were associated with trisomy 13 or 18.
In addition to patency of the DA, sonographic parameters that were significantly associated with unfavorable outcome in our study included hydrops and/or enlarged NT and abnormal Doppler flow velocity profiles. All cases with hydrops and/or reversed flow in the DV, UA or MCA were invariably associated with non-survival. This is in keeping with previous reports that found hydrops and abnormal Doppler parameters to be highly associated with IUFD 3, 4, 10, 15, 26, 27 . Although the causal relationship between dilatation of the pulmonary trunk and branches and the occurrence of bronchomalacia has been described previously 2, 7 , none of the echocardiographic variables, including pulmonary valve annulus, right pulmonary artery diameter and cardiomegaly, was a significant predictor of neonatal respiratory distress and adverse outcome in our study, as well as in previous studies 6, 10, 26, 28 . Although some degree of pulmonary dilatation was present in all of our cases, the 9% incidence of bronchomalacia in those that were liveborn was markedly low and therefore bronchomalacia did not significantly contribute to morbidity in our study. Left ventricular dysfunction predicted mortality in a recent series of prenatally diagnosed cases of APVS with TOF 14 ; however, this parameter was not assessed in our cohort.
Contemporary series on prenatally detected APVS reported significantly improved survival rates of > 80% in liveborn infants with active postnatal care 11, 14 . The survival in our series is similar, with only two NNDs among 13 liveborn infants with active care and no case of infant/childhood death, despite a relatively long period of follow-up. However, if all cases of the cohort are taken into account, the survival rate drops to 27.5%, owing to the large number of TOPs and IUFDs.
In a recent study, none of the three cases of prenatally detected APVS with an intact septum and TA survived without heart transplantation 14 . Conversely, in our series, both infants with TA successfully underwent Fontan palliation with a follow-up of 13 and 3 years, respectively.
In conclusion, APVS with TOF detected in the first and early second trimesters is significantly associated with patency of the DA, abnormal Doppler flow velocity profiles, lethal trisomy, hydrops and/or enlarged NT, and consequently high intrauterine mortality. APVS with isolated TOF and agenesis of DA has a better prognosis, with > 80% survival and low morbidity among live births with active postnatal care.
